TickerFactsScreenerDevelopers

ARS Pharmaceuticals, Inc. (SPRY) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2020: $917.0K2021: $55.0K2022: $199.0K2023: $175.0K2024: $563.0K2025: $339.0K$339.0K
2020Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$339.0K-39.8%
2024$563.0K+221.7%
2023$175.0K-12.1%
2022$199.0K+261.8%
2021$55.0K-94.0%
2020$917.0K—